William Blair Downgrades VistaGen Therapeutics (VTGN) to Market Perform Dec 17, 2025 12:01PM
William Blair Starts VistaGen Therapeutics (VTGN) at Outperform, 'Delivering on an Underappreciated CNS Pipeline' Dec 4, 2023 07:08AM
VistaGen Therapeutics (VTGN) Announces Pricing of $100 Million Underwritten Offering Oct 2, 2023 07:31AM
Vistagen Announces Pricing of $100 Million Underwritten Offering Oct 2, 2023 07:30AM
VistaGen (VTGN) Downgraded at William Blair on PALISADE-1 Failure, "Uncertainty on Path Forward for PH94B" Jul 22, 2022 08:58AM


Jul 13, 2022 04:08PM William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
Jul 7, 2022 08:30AM VistaGen to Participate at William Blair Biotech Focus Conference 2022
Jun 8, 2022 06:08AM "PH94B Has Potential to Open Several New Markets" - William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
May 27, 2022 08:30AM VistaGen to Participate in Upcoming June Investor Conferences
May 26, 2022 07:33AM "PH94B Could Become First Rapid-Onset Treatment for SAD" - William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
Feb 11, 2022 08:24AM William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
Jul 9, 2021 08:30AM VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
Jul 9, 2021 08:30AM VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
Jun 29, 2021 04:15PM VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
Jun 29, 2021 04:15PM VistaGen Therapeutics Reports Fiscal Year 2021 Financial Results and Provides Corporate Update
May 20, 2021 08:00AM VistaGen Therapeutics to Present at Two Investor Conferences in June
Feb 11, 2021 04:30PM VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Feb 11, 2021 04:30PM VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Dec 22, 2020 04:01PM VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
Dec 22, 2020 04:01PM VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
Dec 18, 2020 06:27AM VistaGen Therapeutics (VTGN) Prices Underwritten Public Offering of Common Stock, Conv. Preferred Stock
Dec 18, 2020 06:25AM VistaGen Therapeutics Announces Pricing of Underwritten Public Offering
Dec 17, 2020 04:01PM VistaGen Therapeutics (VTGN) Announces Proposed Underwritten Public Offering
Dec 17, 2020 04:01PM VistaGen Therapeutics Announces Proposed Underwritten Public Offering
Nov 14, 2019 10:37AM William Blair Downgrades VistaGen Therapeutics (VTGN) to Market Perform
Aug 28, 2019 06:15AM William Blair Starts VistaGen Therapeutics (VTGN) at Outperform
Apr 3, 2019 08:30AM VistaGen Therapeutics to Participate in the William Blair 3rd Annual Late-Stage Therapeutics Conference on April 4, 2019
Feb 26, 2019 09:00AM VistaGen Therapeutics (VTGN) Prices 10M Share Offering at $1/Sh
Feb 26, 2019 09:00AM VistaGen Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
Feb 26, 2019 09:00AM VistaGen Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
Feb 25, 2019 04:03PM VistaGen Therapeutics (VTGN) to Offer Common Stock
Feb 25, 2019 04:03PM VistaGen Therapeutics Announces Proposed Public Offering of Common Stock
Feb 25, 2019 04:03PM VistaGen Therapeutics Announces Proposed Public Offering of Common Stock